Literature DB >> 9688682

Divergence of the feeding and thermogenic pathways influenced by NPY in the hypothalamic PVN of the rat.

C M Kotz1, J E Briggs, M K Grace, A S Levine, C J Billington.   

Abstract

Neuropeptide Y (NPY) injected into the paraventricular nucleus (PVN) increases feeding and decreases brown adipose tissue (BAT) uncoupling protein (UCP) and lipoprotein lipase (LPL) mRNA. Previously we reported that the feeding and BAT effects induced by NPY in the PVN are blocked by 50 microg naltrexone (NTX) in the rostral nucleus of the solitary tract (rNTS). We sought to determine whether the effect of rNTS NTX on PVN NPY-induced alterations in energy metabolism occurred at lower doses of NTX. Male Sprague-Dawley rats were fitted with cannulas into two sites: PVN and rNTS. Feeding response, BAT UCP, and LPL mRNA were measured after injection of 0, 5, 10, and 25 microg NTX in the rNTS +/- 1 microg NPY in the PVN. One-hour feeding response to PVN NPY was significantly and dose dependently decreased by 10 and 25 microg rNTS NTX (-23 and -31%, respectively). However, rNTS NTX did not block the PVN NPY-induced decrease in BAT UCP or LPL mRNA. BAT beta-actin mRNA (as a measure of overall changes in gene expression) was unchanged among treatment groups. These results indicate a possible divergence in the PVN NPY feeding-stimulatory/BAT-inhibitory pathway, such that PVN NPY feeding effects may be routed through the rNTS whereas BAT effects may be due to alterations at another neural site.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9688682     DOI: 10.1152/ajpregu.1998.275.2.R471

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

Review 1.  Central nervous system regulation of brown adipose tissue.

Authors:  Shaun F Morrison; Christopher J Madden
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

Review 2.  CNS-targeting pharmacological interventions for the metabolic syndrome.

Authors:  Kerstin Stemmer; Timo D Müller; Richard D DiMarchi; Paul T Pfluger; Matthias H Tschöp
Journal:  J Clin Invest       Date:  2019-08-05       Impact factor: 14.808

3.  Hypothalamic neuropeptide Y (NPY) and the attenuation of hyperphagia in streptozotocin diabetic rats treated with dopamine D1/D2 agonists.

Authors:  Dong-Yih Kuo
Journal:  Br J Pharmacol       Date:  2006-05-15       Impact factor: 8.739

4.  NPY neuron-specific Y2 receptors regulate adipose tissue and trabecular bone but not cortical bone homeostasis in mice.

Authors:  Yan-Chuan Shi; Shu Lin; Iris P L Wong; Paul A Baldock; Aygul Aljanova; Ronaldo F Enriquez; Lesley Castillo; Natalie F Mitchell; Ji-Ming Ye; Lei Zhang; Laurence Macia; Ernie Yulyaningsih; Amy D Nguyen; Sabrina J Riepler; Herbert Herzog; Amanda Sainsbury
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

5.  Sensitivity of the hypothalamic paraventricular nucleus to the locomotor-activating effects of neuromedin U in obesity.

Authors:  Colleen M Novak; Minzhi Zhang; James A Levine
Journal:  Brain Res       Date:  2007-07-13       Impact factor: 3.252

Review 6.  The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.

Authors:  Jeffrey M Witkin; Michael A Statnick; Linda M Rorick-Kehn; John E Pintar; Michael Ansonoff; Yanyun Chen; R Craig Tucker; Roberto Ciccocioppo
Journal:  Pharmacol Ther       Date:  2013-11-01       Impact factor: 12.310

7.  Appetitive and consummatory ingestive behaviors stimulated by PVH and perifornical area NPY injections.

Authors:  Megan J Dailey; Timothy J Bartness
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-02-04       Impact factor: 3.619

Review 8.  The brain and brown fat.

Authors:  Cristina Contreras; Francisco Gonzalez; Johan Fernø; Carlos Diéguez; Kamal Rahmouni; Rubén Nogueiras; Miguel López
Journal:  Ann Med       Date:  2014-06-10       Impact factor: 4.709

9.  Neuropeptide Y suppresses thermogenic and cardiovascular sympathetic nerve activity via Y1 receptors in the paraventricular nucleus and dorsomedial hypothalamus.

Authors:  Zhigang Shi; Alyssa C Bonillas; Jennifer Wong; Stephanie L Padilla; Virginia L Brooks
Journal:  J Neuroendocrinol       Date:  2021-07-08       Impact factor: 3.870

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.